Vertex Pharmaceuticals Inc / Ma

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vertex Pharmaceuticals Inc / Ma
TickerVRTX
CIK #0000875320
CUSIP92532F100
SectorLife Sciences - Pharmaceutical Preparations
Address130 Waverly Street, Cambridge, MA 02139-4242
Source [EDGAR]
CIK Filing 2011 - 2024
[0000875320] 10-K
[0000875320] 10-Q
[0000875320] 3
[0000875320] 4
[0000875320] 5
[0000875320] 8-K
[0000875320] SC 13D
[0000875320] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Capital World Investors Vertex Pharmaceuticals Inc / Ma [2023-02-13] 5.0
FMR LLC Vertex Pharmaceuticals Inc / Ma [2023-02-09] 0.0
BlackRock Inc Vertex Pharmaceuticals Inc / Ma [2023-01-24] 9.4
Vertex Pharmaceuticals Inc / Ma Kymera Therapeutics Inc [2020-09-03] 7.1
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2019-11-26] 0.1
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2018-12-21] 10.1
JPMorgan Chase & Co Vertex Pharmaceuticals Inc / Ma [2016-02-01] 5.1
FMR LLC Vertex Pharmaceuticals Inc / Ma [2015-02-13] 0.0
Price T Rowe Associates Inc /MD/ Vertex Pharmaceuticals Inc / Ma [2015-02-12] 5.5
Wellington Management Co LLP Vertex Pharmaceuticals Inc / Ma [2014-02-14] 7.08
Vanguard Group Inc Vertex Pharmaceuticals Inc / Ma [2014-02-12] 6.73
Jennison Associates LLC Vertex Pharmaceuticals Inc / Ma [2012-02-14] 5.0
Prudential Financial Inc Vertex Pharmaceuticals Inc / Ma [2012-02-14] 5.2
Form 3/4/5 Filer 2011 - 2024
Ambrose Kristen
Vertex Pharmaceuticals Inc / Ma
Arbuckle Stuart A
Sanna Bastiano
Leiden Jeffrey M
McGlynn Margaret G
Lee Yuchun
Kearney Terrence C
Garber Alan M
Carney Lloyd
Bhatia Sangeeta N.
McKenzie Diana
Sachs Bruce I
Upadhyay Suketu
Kewalramani Reshma
Wagner Charles F Jr
Sachdev Amit
Altshuler David
Bozic Carmen
Tatsis Ourania
Biller Jonathan
Liu Joy
Silva Paul M
Parini Michael
Young William D
Ullian Elaine
CRISPR Therapeutics AG
Vertex Pharmaceuticals (Europe) Ltd
Graney Thomas
Smith Ian F
Chodakewitz Jeffrey
Boger Joshua S
Riley Wayne Joseph
Connolly Thomas
Horton Kenneth L
Pace Megan E
Mueller Peter
Stamoulis Christiana
Kelly Lisa
Emmens Matthew
Wysenski Nancy
Winger Dennis L
Howton David T
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 21,669,167.0 23,906,603.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 20,751,150.0
FMR LLC [2023-03-31] DFND 15,308,904.0 16,275,855.0
Capital World Investors [2023-03-31] DFND 16,129,862.0 16,144,423.0
State Street Corp [2023-03-31] DFND 10,529,058.0 12,207,452.0
AllianceBernstein LP [2023-03-31] DFND 7,964,482.0 8,373,273.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 7,517,548.0
JPMorgan Chase & Co [2023-03-31] DFND 5,564,882.0 6,345,046.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 2,935,060.0 6,241,919.0
Geode Capital Management LLC [2023-03-31] DFND 5,396,626.0 5,409,257.0
Jennison Associates LLC [2023-03-31] DFND 4,196,104.0 4,458,221.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 3,389,860.0
Loomis Sayles & Co L P [2023-03-31] DFND 2,728,012.0 3,371,646.0
Clearbridge Investments LLC [2023-03-31] SOLE 3,259,407.0 3,337,741.0
Massachusetts Financial Services Co /MA/ [2023-03-31] SOLE 3,187,004.0 3,272,822.0
Northern Trust Corp [2023-03-31] DFND 600,120.0 2,743,833.0
Bank of America Corp /DE/ [2023-03-31] DFND 304,855.0 2,692,844.0
Morgan Stanley [2023-03-31] DFND 1,884,839.0 2,353,061.0
Legal & General Group Plc [2023-03-31] DFND 1,758,849.0 2,086,331.0
Amundi [2023-03-31] DFND 2,038,311.0 2,038,918.0
Bank of New York Mellon Corp [2023-03-31] DFND 1,551,618.0 1,993,554.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,644,552.0 1,926,255.0
Invesco Ltd. [2023-03-31] DFND 0.0 1,861,368.0
Harding Loevner LP [2023-03-31] SOLE 1,826,624.0 1,826,624.0
Deutsche Bank AG [2023-03-31] DFND 900,847.0 1,754,423.0
UBS Asset Management Americas Inc [2023-03-31] SOLE 1,211,430.0 1,610,623.0
California Public Employees Retirement System [2023-03-31] SOLE 1,479,745.0 1,479,745.0
Envestnet Asset Management Inc [2023-03-31] SOLE 1,451,874.0 1,451,874.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 1,443,133.0 1,443,137.0
Renaissance Technologies LLC [2023-03-31] SOLE 1,397,735.0 1,397,735.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com